These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14028479)

  • 41. [5-HYDROXYTRYPTOPHAN DOPA DECARBOXYLASE IN NERVOUS AND CARDIAC TISSUES IN THE MOLLUSC HELIX POMATIA. INTERACTION OF SUBSTRATES IN VITRO].
    CARDOT J
    C R Hebd Seances Acad Sci; 1964 Jul; 259():902-4. PubMed ID: 14190531
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of administration of amino acids, especially of L-DOPA and -methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. 3. Alterations of cerebrospinal fluid in patients with Huntington's chorea after -methyldopa or L-DOPA].
    Simanyi M; Gerstenbrand F; Gründig E; Schedl R; Weiss H
    Z Neurol; 1973 Mar; 204(1):67-80. PubMed ID: 4121504
    [No Abstract]   [Full Text] [Related]  

  • 43. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 44. L-dopa or methyldopa?
    Tice LF
    Am J Pharm Sci Support Public Health; 1972; 144(3):71-2. PubMed ID: 5068775
    [No Abstract]   [Full Text] [Related]  

  • 45. Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1972 Jun; 47(6):389-95. PubMed ID: 5041685
    [No Abstract]   [Full Text] [Related]  

  • 46. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
    Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
    Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
    [No Abstract]   [Full Text] [Related]  

  • 47. Another hypotensive agent--methyldopa.
    DALEY D; EVANS B
    Br Med J; 1962 Jul; 2(5298):156-8. PubMed ID: 13883201
    [No Abstract]   [Full Text] [Related]  

  • 48. ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.
    SMITH CB
    J Pharmacol Exp Ther; 1963 Dec; 142():343-50. PubMed ID: 14098331
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of methyldopa in carcinoid disease.
    NICHOLSON GI; IRVINE RO
    Br Med J; 1962 Oct; 2(5310):961-3. PubMed ID: 14479461
    [No Abstract]   [Full Text] [Related]  

  • 50. Spontaneous formation of conjugates of alpha-methyl-DOPA and DOPA with serum proteins and experimental production of specific antibodies against these haptens.
    Cîrstea M; Suhaciu G; Cîrje M
    Physiologie; 1983; 20(1):3-10. PubMed ID: 6405406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STUDIES ON THE ABSORPTION, METABOLISM AND EXCRETION OF METHYLDOPA AND OTHER CATECHOLS AND THEIR INFLUENCE ON AMINO ACID TRANSPORT IN RATS.
    YOUNG JA; EDWARDS KD
    J Pharmacol Exp Ther; 1964 Jul; 145():102-12. PubMed ID: 14209502
    [No Abstract]   [Full Text] [Related]  

  • 52. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
    Sweet RD; Lee JE; McDowell F
    Trans Am Neurol Assoc; 1971; 96():59-65. PubMed ID: 5159130
    [No Abstract]   [Full Text] [Related]  

  • 53. The metabolism of L-3-O-methyldopa, a precursor of dopa in man.
    Kuruma I; Bartholini G; Tissot R; Pletscher A
    Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811
    [No Abstract]   [Full Text] [Related]  

  • 54. Incorporation of L-dopa, L-alpha-methyldopa and DL-isoproterenol into guinea pig hair.
    Harrison WH; Gray RM; Solomon LM
    Acta Derm Venereol; 1974; 54(4):249-53. PubMed ID: 4136810
    [No Abstract]   [Full Text] [Related]  

  • 55. [ACTION OF 5-HTP/DOPA DECARBOXYLASE INHIBITORS ON DIURESIS, URINARY ELECTROLYTES AND RELEASE OF THE ANTIDIURETIC HORMONE].
    CAHN J; HEROLD M; BARRE N
    C R Seances Soc Biol Fil; 1964; 158():1331-5. PubMed ID: 14210566
    [No Abstract]   [Full Text] [Related]  

  • 56. SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.
    DAY MD; RAND MJ
    Br J Pharmacol Chemother; 1964 Feb; 22(1):72-86. PubMed ID: 14126060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
    Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
    [No Abstract]   [Full Text] [Related]  

  • 58. Enantioseparation of dopa and related compounds by cyclodextrin-modified microemulsion electrokinetic chromatography.
    Borst C; Holzgrabe U
    J Chromatogr A; 2008 Sep; 1204(2):191-6. PubMed ID: 18538332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Agranulocytosis caused by methyl dopa (Aldomet).
    HALLWRIGHT GP
    N Z Med J; 1961 Dec; 60():567-70. PubMed ID: 13903962
    [No Abstract]   [Full Text] [Related]  

  • 60. [ON THE PROBLEMS OF RESEARCH ON PIGMENTATION].
    IPPEN H
    Dtsch Med Wochenschr; 1964 Apr; 89():798-800. PubMed ID: 14160347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.